These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17208465)

  • 1. Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting.
    Allain H; Schück S; Nachit-Ouinekh F; Plouin P; Brunon AM; Boulliat J; Mercier F; Slama A; Baulac M; El Hasnaoui A
    Seizure; 2007 Mar; 16(2):173-84. PubMed ID: 17208465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen.
    Kustra RP; Meador KJ; Evans BK; Leschek-Gelman LM; Groenke DA; Hammer AE; Nanry KP; Messenheimer JA;
    Seizure; 2005 Jun; 14(4):254-61. PubMed ID: 15911360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid.
    Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Morales MD;
    Seizure; 2010 Sep; 19(7):432-8. PubMed ID: 20663691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.
    Gillham R; Kane K; Bryant-Comstock L; Brodie MJ
    Seizure; 2000 Sep; 9(6):375-9. PubMed ID: 10985991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved mood states with lamotrigine in patients with epilepsy.
    Cramer JA; Hammer AE; Kustra RP
    Epilepsy Behav; 2004 Oct; 5(5):702-7. PubMed ID: 15380122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lamotrigine on sexual function in patients with epilepsy.
    Gil-Nagel A; López-Muñoz F; Serratosa JM; Moncada I; García-García P; Alamo C
    Seizure; 2006 Apr; 15(3):142-9. PubMed ID: 16434217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire].
    Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Barrera S; Morales MD;
    Neurologia; 2008 Apr; 23(3):157-67. PubMed ID: 18370335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life improvement with conversion to lamotrigine monotherapy.
    Cramer JA; Hammer AE; Kustra RP
    Epilepsy Behav; 2004 Apr; 5(2):224-30. PubMed ID: 15123024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Pompili A; Carapella CM
    Epileptic Disord; 2012 Dec; 14(4):388-97. PubMed ID: 23248037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in seizure-free patients with epilepsy on monotherapy.
    Auriel E; Landov H; Blatt I; Theitler J; Gandelman-Marton R; Chistik V; Margolin N; Gross B; Parmet Y; Andelman F; Neufeld MY
    Epilepsy Behav; 2009 Jan; 14(1):130-3. PubMed ID: 18926930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM
    Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
    Machado RA; García VF; Astencio AG; Cuartas VB
    Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.
    Thome-Souza S; Valente KD
    Pediatr Neurol; 2013 Jun; 48(6):436-42. PubMed ID: 23668867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.